Condition (MeSH)
Magnesium Deficiency
ClinicalTrials.gov lists 23 trials for Magnesium Deficiency or a narrower condition beneath it.
Search trials, drugs, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Trials per phase
23 of the 23 trials are tagged with Magnesium Deficiency itself; the rest are tagged with a narrower condition beneath it.
When did Magnesium Deficiency trials start? (11)
Shown in this order: most recent first, 1990 onwards. 2026 is partial: trials registered with a 2026 start date so far, not a full year.
Trials over time, by phase
- Phase 2/3
- Phase 3
- Phase 4
- Not applicable
- Observational
Top of scale: 4
Trials registered with a start date in each year, 1990 onward, stacked by phase (complete years only; the current partial year is in the table's notes). The table below lists the same counts, most recent years first.
| Year | Trials started |
|---|---|
| 2025 | 2 |
| 2022 | 3 |
| 2021 | 3 |
| 2019 | 1 |
| 2018 | 2 |
| 2017 | 1 |
| 2016 | 4 |
| 2015 | 2 |
| 2014 | 1 |
| 2012 | 2 |
Showing 10 of 11 earlier years.
No forecast is made for this condition: it averages 1.2 trial starts a year over the five years to September, under the 5 a year the method needs.
Recruitment duration, a model prediction: 2 trials still running at the 2026-10-09 snapshot, fewer than the 5 needed for a median. Source: ClinicalTrials.gov / AACT (CTTI), public domain.
What phase are Magnesium Deficiency trials in? (5)
Shown in this order: phase order.
Show the trials by phase as a table
| Phase | Trials |
|---|---|
| Phase 2/3 | 1 |
| Phase 3 | 3 |
| Phase 4 | 3 |
| Not applicable | 11 |
| Observational | 5 |
How many Magnesium Deficiency trials are recruiting? (4)
Shown in this order: the order a trial moves through, from not yet recruiting to unknown.
| Status | Trials |
|---|---|
| Recruiting | 1 |
| Completed | 15 |
| Terminated | 1 |
| Unknown status | 6 |
Status as registered on ClinicalTrials.gov. Each trial is counted once.
Which lead sponsors run the most Magnesium Deficiency trials? (6)
Shown in this order: most trials first. Lead sponsors the registry classes as industry, NIH, US federal, other government or network. A hospital or university the registry files as government can appear here. Sponsors it classes as academic or other are shown on the full page, because that class cannot separate an institution from a named investigator.
| Sponsor | Trials |
|---|---|
| Astra USA | 1 |
| Coordinación de Investigación en Salud, Mexico | 1 |
| My Goodlife SAS | 1 |
| Natural Calm Canada | 1 |
| Qualia Life Sciences | 1 |
Showing 5 of 6 sponsors.
Which drugs are being tested for Magnesium Deficiency? (5)
Shown in this order: most trials first. One row per drug, matched to a single molecule under all its names, ranked by number of trials.
| Drug | Trials |
|---|---|
| Magnesia | 2 |
| Calcium/Vitamin D | 2 |
| Calcium-vitamin D3 | 1 |
| Foscarnet | 1 |
| Potassium chloride powder | 1 |
Interventions as named in the registry (3)
Shown in this order: most trials first.
| Drug | Trials |
|---|---|
| Vitamin D and Calcium | 1 |
| Intravenous Infusion of Magnesium Sulfate | 1 |
| Pabrinex | 1 |
These are the names sponsors entered on ClinicalTrials.gov that we have not matched to a single molecule. Some are drugs under a brand or code name; others are procedures, doses or arm labels.
Which publications cover Magnesium Deficiency? (99)
Shown in this order: major-topic papers first, then newest, then most linked to trials.
| Publication | Journal | Year | Major topic |
|---|---|---|---|
| Short Report: Influence of Dark Chocolate Intake on Magnesium Status in Hemodialysis Patients. | Journal of renal nutrition : the official journal of the Council on Renal Nutrition of the National Kidney Foundation | 2025 | Yes |
| Magnesium Deficiency and Cardiometabolic Disease. | Nutrients | 2023 | Yes |
| The Role of Magnesium in the Pathogenesis of Metabolic Disorders. | Nutrients | 2022 | Yes |
| Magnesium in Aging, Health and Diseases. | Nutrients | 2021 | Yes |
| Hypomagnesemia at the time of autologous stem cell transplantation for patients with diffuse large B-cell lymphoma is associated with an increased risk of failure. | Blood cancer journal | 2021 | Yes |
Showing 5 of 99 publications.
Not on this page
Not measured: delivery record.
Checked, with nothing recorded for this condition: serious adverse events in this condition's trials, prevalence, rare-disease identity, and sub-conditions in mesh.